Sort
30,917 grants matching “tumor microenvironment”
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
$384,412John Digiovanni · University Of Texas At Austin · R01 · FY2019 · CA
Functional Dissection of Metabolic-Sensing Proline Hydroxylation Pathways
$384,375Yue Chen · University Of Minnesota · R35 · FY2023 · GM
Functional Dissection of Metabolic-Sensing Proline Hydroxylation Pathways
$384,375Yue Chen · University Of Minnesota · R35 · FY2025 · GM
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
$384,355Joan Siefert Brugge · Whitehead Institute For Biomedical Res · P01 · FY2009 · CA
Informatics Tools for Tumor Heterogeneity in Multiplexed Fluorescence Images
$384,355Srinivas Chakra Chennubhotla · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · CA
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
$384,300Guangwen Ren · Jackson Laboratory · R37 · FY2021 · CA
Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs
$384,300Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
$384,300Guangwen Ren · Jackson Laboratory · R37 · FY2022 · CA
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
$384,283Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$384,278Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2023 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$384,278Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2022 · CA
Ovarian Cancer: Mechanisms of Neuroendocrine Regulation
$384,255Anil K Sood · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
$384,242Xiaoliu Zhang · University Of Houston · R01 · FY2025 · CA
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
$384,242Xiaoliu Zhang · University Of Houston · R01 · FY2022 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$384,229James Louis Rubenstein · University Of California, San Francisco · R01 · FY2014 · CA
Controlling cancer with aspirin-triggered stimulation of resolution
$384,219Dipak Panigrahy · Boston Children'S Hospital · R01 · FY2012 · CA
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
$384,163Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Synergy of Radiation and Immunotherapy: New Approaches
$384,156Yang-Xin Fu · Ut Southwestern Medical Center · R01 · FY2016 · CA
Mechanisms of Synergistic Regulation of Stem/Progenitors
$384,150Hal E. Broxmeyer · Indiana University Indianapolis · R01 · FY2015 · HL
Nutrient Sensing and Transcriptional Regulation
$384,140Donald E Ayer · University Of Utah · R01 · FY2022 · CA
Microfluidic 3D Assays for Metastatic Cancer
$384,136Roger D. Kamm · Massachusetts Institute Of Technology · R33 · FY2013 · CA
RNase H2 is a novel therapeutic target in triple negative breast cancer
$384,115Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
RNase H2 is a novel therapeutic target in triple negative breast cancer
$384,115Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
MAIT cells as a therapeutic approach for gastrointestinal cancers
$384,092Daniel Ted Leung · University Of Utah · R21 · FY2024 · CA
Center for Modeling Tumor Cell Migration Mechanics: Administrative Core
$384,080David J Odde · University Of Minnesota · U54 · FY2016 · CA